Literature DB >> 3934894

Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.

K Kamoi, T Mitsuma, H Sato, M Yokoyama, K Washiyama, R Tanaka, O Arai, N Takasu, T Yamada.   

Abstract

A 46-year-old woman had signs of thyrotoxicosis and galactorrhoea. Serum immunoreactive TSH and its alpha-subunit increased in the presence of high serum triiodothyronine (T3), thyroxine (T4), and free T4 concentrations, whereas beta-subunit TSH was undetectable. Exogenous TRH failed to increase serum TSH. Serum TSH was markedly suppressed by glucocorticoid, but was increased by antithyroid drug. L-Dopa or bromocriptine partially suppressed, but nomifensine had no influence on serum TSH. Serum prolactin (Prl) was above normal and markedly increased by TRH, but depressed by bromocriptine and not suppressed by nomifensine. Plasma TRH was normal in the hyperthyroid state, but was increased by glucocorticoid and antithyroid drug. Excess thyroid hormone depressed plasma TRH concentrations. Basal serum GH levels were constantly low. Transsphenoidal removal of the tumour normalized serum hormones (T3, T4 free T4, TSH, alpha-subunit and Prl), and eradicated the clinical signs of hyperthyroidism and galactorrhoea. Histological study of the tumour tissue demonstrated both thyrotrophes and somatotrophes. A reciprocal relationship between serum TSH and T4 concentrations shifted to a higher level before but was normalized after removal of the tumour. Ten months later, the clinical signs of thyrotoxicosis and the increase in serum thyroid hormone recurred without a concomitant increase in serum TSH and its alpha-subunit. Thyroidal auto-antibodies were slightly positive, but thyrotrophin-binding inhibitor immunoglobulin (TBII) was negative. Administration of antithyroid drug produced a euthyroid state, but 3 years later, discontinuation of the treatment resulted in recurrent hyperthyroidism without suppressed plasma TRH and with no evidence of regrowth of the pituitary tumour. It is suggested that the patient initially had hyperthyroidism owing to excessive TSH secretion from the tumour caused by abnormal TRH secretion, and subsequently had hyperthyroidism owing to Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3934894     DOI: 10.1530/acta.0.1100373

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  11 in total

1.  Coexistence of thyroid-stimulating hormone-secreting pituitary adenoma and graves' hyperthyroidism.

Authors:  Mahdi Kamoun; Michèle d'Herbomez; Christine Lemaire; Armelle Fayard; Rachel Desailloud; Damien Huglo; Jean-Louis Wemeau
Journal:  Eur Thyroid J       Date:  2013-11-20

2.  Severe hyperthyroidism due to neoplastic TSH hypersecretion in an old man.

Authors:  D Rubello; B Busnardo; M E Girelli; M Piccolo
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

Review 3.  Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment.

Authors:  N Sanno; A Teramoto; R Y Osamura
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

Review 4.  Thyrotropin-secreting pituitary adenomas: epidemiology, diagnosis, and management.

Authors:  Fatemeh G Amlashi; Nicholas A Tritos
Journal:  Endocrine       Date:  2016-01-21       Impact factor: 3.633

5.  A case of thyrotropin-producing pituitary adenoma, accompanied by an increase in anti-thyrotropin receptor antibody after tumor resection.

Authors:  K Kageyama; H Ikeda; S Sakihara; T Nigawara; K Terui; S Tsutaya; E Matsuda; M Shoji; M Yasujima; T Suda
Journal:  J Endocrinol Invest       Date:  2007-12       Impact factor: 4.256

6.  Thyrotropin-producing pituitary adenoma simultaneously existing with Graves' disease: a case report.

Authors:  Nobuhiko Arai; Makoto Inaba; Takamasa Ichijyo; Hiroshi Kagami; Yutaka Mine
Journal:  J Med Case Rep       Date:  2017-01-06

7.  Thyroid-stimulating hormone-secreting pituitary adenoma presenting with recurrent hyperthyroidism in post-treated Graves' disease: a case report.

Authors:  Yoshikazu Ogawa; Teiji Tominaga
Journal:  J Med Case Rep       Date:  2013-01-21

8.  Thyrotropinoma with Graves' disease detected by the fusion of indium-111 octreotide scintigraphy and pituitary magnetic resonance imaging.

Authors:  Kursat Okuyucu; Engin Alagoz; Nuri Arslan; Abdullah Taslipinar; Mehmet Salih Deveci; Erol Bolu
Journal:  Indian J Nucl Med       Date:  2016 Apr-Jun

9.  Case report of recurrent atrial fibrillation induced by thyrotropin-secreting pituitary adenoma with Graves' disease.

Authors:  Jiaqi Li; Huiwen Tan; Juan Huang; Dan Luo; Ying Tang; Ruichao Yu; Hui Huang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

10.  A remarkable case of thyrotoxicosis initially caused by graves' disease followed by a probable TSHoma - a case report.

Authors:  Mark Quinn; Waiel Bashari; Diarmuid Smith; Mark Gurnell; Amar Agha
Journal:  BMC Endocr Disord       Date:  2020-08-27       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.